This week, on the precipice of a historic U.S. election I will start with a brief commentary on making portfolio decisions based on election outcomes.
Back by popular demand we have decided to make our new Case For, Case Against segment a permanent fixture. Our head of income research, Mr. Aaron Dunn will make his highly anticipated first argument facing off against Brennan. In the line of fire is Apple Inc. (AAPL: NASDAQ), the iPhone company which should need no introduction. While the stock sold off this week after its quarterly results included a lack of forward guidance, the consumer tech giant is up 47% this year. We argue both sides of the BUY/SELL argument for the stock.
With a hat tip to Movember and men’s cancer prevention and treatment, this week’s Your Stock, Our Take was sent in from a listener on Profound Medical Corp. (PRN: TSX), a medical technology company developing medical treatments with its core technology used to ablate the prostate gland. We let you know if the share price gains are justifiable based on the underlying cash flow at present.
Stock Talk Podcast Episode 252
Stock Talk Podcast Episode 251
Stock Talk Podcast Episode 250
Stock Talk Podcast Episode 249
Stock Talk Podcast Episode 248
Stock Talk Podcast Episode 247
Stock Talk Podcast Episode 246
Stock Talk Podcast Episode 245
Stock Talk Podcast Episode 244
Stock Talk Podcast Episode 243
Stock Talk Podcast Episode 242
Stock Talk Podcast Episode 241
Stock Talk Podcast Episode 240
Stock Talk Podcast Episode 239 - Prediction Special
Stock Talk Podcast Episode 238
Stock Talk Podcast Episode 237
Stock Talk Podcast Episode 236
Stock Talk Podcast Episode 235
Stock Talk Podcast Episode 234
Stock Talk Podcast Episode 233
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Aligned Money Show
Dubai Property Podcast
IBKR Podcasts
The Ramsey Show
The Clark Howard Podcast